» Articles » PMID: 27872574

Prevalence and Pattern of Dyslipidemia in Hyperglycemic Patients and Its Associated Factors Among Pakistani Population

Overview
Specialty Biology
Date 2016 Nov 23
PMID 27872574
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

In diabetes mellitus dyslipidemia is one of the major risk factors for cardiovascular disease. In type 2 diabetes mellitus early detection and treatment of dyslipidemia can avoid risk for cardiovascular disorder. The present study was carried to determine the prevalence and pattern of hyperlipidemia in patients with hyperglycemia. The cross sectional study was done in different laboratories of Pakistan, the laboratories served patients referred from different government and private hospitals between July 2014 and June 2015. All known cases of diabetes mellitus were evaluated for their lipid profile. Totally 200 diabetic patients were included in the study in which 120 (60%) were males and 80 (40%) were females. Prevalence of dyslipidemia among diabetic males was 97.18% while for females 87.15%. Among dyslipidemic male the proportion with mixed dyslipidemic patients was 17.5%, combined two parameters dyslipidemia was 47.5% and isolated single parameter dyslipidemia was 35%. In females these proportions in mixed, combined two parameters and isolated single parameter were 16.25%, 51.25% and 32.5%, respectively. Majority of hyperglycemic patients were dyslipidemic. The most prevalent pattern among male was combined dyslipidemia with high triglycerides (TG) and low High Density Lipoprotein (HDL) and in female it was high Low Density Lipoprotein (LDL) and low HDL. The most prevalent lipid abnormality in our study was low HDL followed by high TG.

Citing Articles

Patterns and Factors Associated with Dyslipidemia Among Patients with Diabetes Mellitus Attending Hoima Regional Referral Hospital, Uganda.

Hirsi A, Abdi A, Peris A, Jacinto A, Muhammad P, Nur I Int J Gen Med. 2025; 18():73-86.

PMID: 39801925 PMC: 11725251. DOI: 10.2147/IJGM.S494941.


RNA Interference Unleashed: Current Perspective of Small Interfering RNA (siRNA) Therapeutics in the Treatment of Neuropathic Pain.

Saha P, Sharma S ACS Pharmacol Transl Sci. 2024; 7(10):2951-2970.

PMID: 39416962 PMC: 11475279. DOI: 10.1021/acsptsci.4c00329.


Apolipoprotein E Gene Variation in Pakistani Subjects with Type 2 Diabetes with and without Cardiovascular Complications.

Nadeem S, Maqbool T, Qureshi J, Altaf A, Naz S, Azhar M Medicina (Kaunas). 2024; 60(6).

PMID: 38929578 PMC: 11205396. DOI: 10.3390/medicina60060961.


Recent Patterns and Assessment of Long-term Complications followi ngSARS-CoV-2 Infection and Vaccination in the Context of Diabet esPrevalence among Blood Donors.

Alqahtani T, Ali Alghamdi M, Baig M, Al-Abbasi F, Sheikh R, Almalki N Curr Diabetes Rev. 2024; 20(9):e110124225520.

PMID: 38415496 DOI: 10.2174/0115733998274390231110050809.


Patterns of dyslipidemia and its associated factors among prediabetic subjects. A cross-sectional study at a primary care clinic.

Siddiqui S, Harun S, Sheikh Ghadzi S, Wahid N, Hassan A, Zainal H Malays Fam Physician. 2024; 18:73.

PMID: 38213389 PMC: 10781612. DOI: 10.51866/oa.125.


References
1.
Gustafsson I, Brendorp B, Seibaek M, Burchardt H, Hildebrandt P, Kober L . Influence of diabetes and diabetes-gender interaction on the risk of death in patients hospitalized with congestive heart failure. J Am Coll Cardiol. 2004; 43(5):771-7. DOI: 10.1016/j.jacc.2003.11.024. View

2.
Abou-Seif M, Youssef A . Evaluation of some biochemical changes in diabetic patients. Clin Chim Acta. 2004; 346(2):161-70. DOI: 10.1016/j.cccn.2004.03.030. View

3.
Vinter-Repalust N, Jurkovic L, Katic M, Simunovic R, Petric D . [Disease duration, patient compliance and presence of complications in diabetic patients]. Acta Med Croatica. 2007; 61(1):57-62. View

4.
Haffner S . Dyslipidemia management in adults with diabetes. Diabetes Care. 2003; 27 Suppl 1:S68-71. DOI: 10.2337/diacare.27.2007.s68. View

5.
Al-Adsani A, Memon A, Suresh A . Pattern and determinants of dyslipidaemia in type 2 diabetes mellitus patients in Kuwait. Acta Diabetol. 2005; 41(3):129-35. DOI: 10.1007/s00592-004-0156-9. View